The American Society of Dermatopathology

Dermatopathology Seminars

adsp-telemedicine.pngBack by Popular Demand! This year Dermatopathology Seminars will be only held in a Zoom room on Thursday, October 20. Only attendees who register in advance will have access to the session. Spots are limited and sessions will fill fast. 

1.25 AMA PRA Category 1 Credits™ per session

Fee: $75 per session

ONLINE REGISTRATION ONLY

  • Sessions will be offered Thursday, October 20 only.
  • Each session is scheduled for one hour and fifteen minutes.
  • All sessions are limited to 30 participants.
  • A $75 registration fee per session is required.

Note: Select seminars with care. All selections are final. ASDP will not assist in the exchange, trading or resale of tickets prior to or during the annual meeting.

Schedule

Thursday, October 20

10:00 a.m. - 11:15 a.m. CT
 
Seminar 1
Problematic Pigmented ‎Lesions: An Approach to Diagnosis
Alina G. Bridges, DO
This session will provide a practical ‎approach to the diagnosis of problematic ‎pigmented lesions, including general ‎guidelines, suggestions for common ‎challenges, potential diagnostic pitfalls, ‎opinions from trusted colleagues, and ‎appropriate use of ancillary ‎immunostains and molecular techniques. Entities ‎discussed will include non-‎melanocytic lesions that can mimic melanocytic ‎lesions, malignant melanoma ‎variants that can mimic benign lesions. Difficult ‎to resolve pigmented lesions, ‎including atypical Spitz lesions, cellular blue nevi ‎and deep penetrating ‎variants, and nevi from special sites will also be ‎presented.‎
     
Seminar 2
Point-Counterpoint: ‎Ethical Controversies in Dermatopathology
Benjamin K. Stoff, MD
This interactive, case-based ‎seminar will review foundational and ‎contemporary ethical controversies in ‎dermatopathology using a point-‎counterpoint format. Practical approaches to ‎resolving ethically-challenging ‎scenarios in dermatopathology will be ‎discussed. Cases will be drawn from the ‎ASDP member survey data about ‎ethical issues in dermatopathology, as well ‎as recent literature.‎
     
1:00 p.m. - 2:15 p.m. CT
 
Seminar 3
The Evolution of COVID-19 in the Skin: Where are we Now?
Carrie Kovarik, MD
COVID-19 infection has been associated with various skin manifestations, some of which are related to the severity of infection. COVID-19 vaccines have also been reported to cause a variety of skin eruptions. As the pandemic evolves, so have the skin manifestations of COVID. This session will discuss the cutaneous entities that are still relevant, when to suspect them, and how to make the clinical-pathologic correlation.
     
Seminar 4
Mistakes Not to Make – Pitfalls in the Diagnosis of Cutaneous Lymphomas
Alexandra C. Hristov, MD
This session will focus on easy to make mistakes in the diagnosis of cutaneous ‎lymphomas that ‎have significant implications for patients.  In particular, ‎reviewed cases will include: aggressive ‎lymphomas mimicking mycosis ‎fungoides, rare variants of lymphomatoid papulosis that resemble ‎more ‎aggressive lymphomas, primary cutaneous CD4-positive small/medium ‎lymphoproliferative ‎disorder (how to recognize it and how to distinguish it ‎from more aggressive lymphomas), important ‎differential considerations in ‎the diagnosis of primary cutaneous diffuse large B-cell lymphoma, leg ‎type, ‎and pitfalls in the diagnosis of primary cutaneous follicle center lymphoma.‎
     
3:00 p.m. - 4:15 p.m. CT
 
Seminar 5
Dermatopathology Appropriate Use Criteria: Incorporating Them Into Your Everyday Practice
Claudia I. Vidal, MD & Patrick O. Emanuel, MBChB, Dip Arts
The ASDP recently developed appropriate use criteria (AUC) to help guide dermatopathologists in the selection of ancillary tests. In this seminar, participants will review cases and discuss with subgroup experts how the AUC can be applied.
     
Seminar 6
Artificial Intelligence in ‎Dermatopathology: Where are We?‎
Kiran Motaparthi, MD and Jason B. Lee,‎ MD
As integration of artificial intelligence ‎‎(AI) continues to increase throughout all ‎medical specialties, the development ‎of AI-augmented dermatopathology is in ‎its early stages. This seminar will ‎provide updates on the status of deep ‎learning in dermatopathology and ‎explore its future roles and their potential ‎impact on the specialty.‎‎
     
5:00 p.m. - 6:15 p.m. CT
 
Seminar 7
The ‎‎"Path" to Understanding, Navigating and Avoiding Medical Malpractice ‎‎Litigation
Jodi J. Speiser, MD and Jennifer De Kock, JD
This seminar will explore the basic ‎tenets and principles of malpractice ‎litigation, tools for testifying at ‎malpractice depositions, and present ‎opportunities for risk mitigation in the ‎histologic diagnosis of cutaneous ‎neoplasms.‎
     
Seminar 8
The Latest and Greatest! What’s new in Dermatology, Pathology and Dermatopathology Diagnostics
Nicholas Logemann, DO
The fields of dermatology and dermatopathology reside at a unique juxtaposition where clinical and pathologic diagnostic modalities frequently overlap (e.g., reflectance confocal microscopy).  Diagnostic methods continually evolve and this session will provide a broad overview of the vast array of new, developing and sometimes lesser known diagnostic tests, devices and technologies employed by both dermatologists and dermatopathologists.
     
7:00 p.m. - 8:15 p.m. CT
 
Seminar 9
Nevus, Melanoma or ‎Something Else? Mesenchymal Tumors with Melanocytic ‎Differentiation
Konstantinos D. Linos, MD
Many soft tissue tumors can be ‎encountered in superficial locations. This ‎seminar will focus on challenging ‎mesenchymal neoplasms with true ‎melanocytic differentiation, which often ‎fall subject to many diagnostic pitfalls. ‎In addition, selected S100/SOX10 ‎positive mesenchymal tumors that can ‎potentially create diagnostic difficulties ‎will also be covered.‎
     
Seminar 10
Artificial Intelligence in (Dermato)pathology
Randie H. Kim, MD, PhD
This seminar will provide an ‎introduction to the concept of deep learning and ‎its applications in healthcare. ‎The role of deep learning in the field of ‎pathology, with a closer look into its ‎strengths and limitations will also be ‎discussed.‎